An, observational study to evaluate the efficacy and safety of daptomycin in suspected or culture proven gram positive bacteremia in adults with End Stage Renal Disease on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis
Latest Information Update: 03 Jul 2019
Price :
$35 *
At a glance
- Drugs Daptomycin (Primary)
- Indications Gram-positive infections
- Focus Therapeutic Use
- Sponsors Novartis
- 15 Jan 2013 New trial record